Other languages Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Real-time Estimate Cboe BZX Other stock markets 12:04:24 2024-06-10 pm EDT			5-day change	1st Jan Change
2.925 ^USD	-2.82%		-4.59%	-32.64%

May. 14	Transcript : Alimera Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14	Alimera Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alimera Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14
Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	Mar. 19
Alimera Sciences, Inc. Provides Revenue Guidance for the Year 2024	Mar. 07
Alimera Sciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 07
Alimera Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07
Alimera Completes Recruitment for the Synchronicity Study	Jan. 04
Alimera Sciences, Inc. Appoints Todd Wood as President of U.S. Operations	Dec. 12
Alimera Sciences, Inc Appoints Maggie A. Pax to its Board of Directors	Nov. 08
Alimera Announces Scientific Data Highlighting ILUVIEN to Be Presented at the American Academy of Ophthalmology	23-10-31
Alimera Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26
Alimera Sciences Names Jason Werner as COO	23-10-03
Alimera Sciences, Inc. Announces Management Appointments	23-10-03
Alimera Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Alimera Sciences, Inc. Announces Resignation of C. Daniel Myers as Director	23-06-29
Insider Buy: Alimera Sciences	23-05-19
Wall Street Set to Open Higher; Investors Look to Powell Speech for Fed Action Hints	23-05-19
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	23-05-18
EyePoint Sells Yutiq Rights to Alimera Sciences for $82.5 Million	23-05-18
Alimera Sciences, Inc. Announces Appointment of Jason Werner to Board of Directors	23-05-18
Alimera Sciences, Inc. Announces Board Changes	23-05-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Other languages

Filters